2007
Predicting treatment outcome following 24 weeks peginterferon α-2a/ribavirin therapy in patients infected with HCV genotype 1: Utility of HCV-RNA at Day 0, Day 22, Day 29, and Week 6 [3]
Publication
Publication
Hepatology , Volume 45 - Issue 1 p. 258- 259